282 related articles for article (PubMed ID: 33589555)
1. Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis.
Horne A; von Bahr Greenwood T; Chiang SCC; Meeths M; Björklund C; Ekelund M; Erensjö P; Berg S; Hagelberg S; Bryceson YT; Andersson U; Henter JI
J Rheumatol; 2021 Oct; 48(10):1596-1602. PubMed ID: 33589555
[TBL] [Abstract][Full Text] [Related]
2. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G
J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
[TBL] [Abstract][Full Text] [Related]
3. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
4. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
[TBL] [Abstract][Full Text] [Related]
5. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
Krei JM; Møller HJ; Larsen JB
Clin Exp Immunol; 2021 Feb; 203(2):174-182. PubMed ID: 33128796
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.
Jesudas R; Nichols KE
Curr Opin Allergy Clin Immunol; 2022 Dec; 22(6):364-370. PubMed ID: 36206094
[TBL] [Abstract][Full Text] [Related]
7. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
9. Unmasking of systemic lupus erythematosus in a patient with hemophagocytic lymphohistiocytosis- macrophage activation syndrome (HLA-MAS) and diffuse alveolar hemorrhage.
Sukhadiya P; Kumar P; Meena DS; Kumar P H A; Vijayan N; Garg P; Garg MK
Reumatismo; 2023 Mar; 74(4):. PubMed ID: 36942984
[TBL] [Abstract][Full Text] [Related]
10. Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
Vandenhaute J; Wouters CH; Matthys P
Front Immunol; 2019; 10():3089. PubMed ID: 32010140
[TBL] [Abstract][Full Text] [Related]
11. Hemophagocytic Lymphohistiocytosis Gene Variants in Childhood-Onset Systemic Lupus Erythematosus With Macrophage Activation Syndrome.
Lahiry P; Naumenko S; Couse M; Liao F; Dominguez D; Knight A; Levy DM; Misztal M; Ng LWK; Hiraki LT
J Rheumatol; 2022 Oct; 49(10):1146-1151. PubMed ID: 35649546
[TBL] [Abstract][Full Text] [Related]
12. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
[TBL] [Abstract][Full Text] [Related]
13. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome.
Inoue N; Schulert GS
Arthritis Res Ther; 2023 Mar; 25(1):48. PubMed ID: 36964620
[TBL] [Abstract][Full Text] [Related]
14. An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome.
Taylor ML; Hoyt KJ; Han J; Benson L; Case S; Chandler MT; Chang MH; Platt C; Cohen EM; Day-Lewis M; Dedeoglu F; Gorman M; Hausmann JS; Janssen E; Lee PY; Lo J; Priebe GP; Lo MS; Meidan E; Nigrovic PA; Roberts JE; Son MBF; Sundel RP; Alfieri M; Yeun JC; Shobiye DM; Degar B; Chang JC; Halyabar O; Hazen MM; Henderson LA
J Rheumatol; 2022 Sep; 49(9):1042-1051. PubMed ID: 35840156
[TBL] [Abstract][Full Text] [Related]
15. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
[TBL] [Abstract][Full Text] [Related]
16. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Davì S; Minoia F; Pistorio A; Horne A; Consolaro A; Rosina S; Bovis F; Cimaz R; Gamir ML; Ilowite NT; Kone-Paut I; Feitosa de Oliveira SK; McCurdy D; Silva CA; Sztajnbok F; Tsitsami E; Unsal E; Weiss JE; Wulffraat N; Abinun M; Aggarwal A; Apaz MT; Astigarraga I; Corona F; Cuttica R; D'Angelo G; Eisenstein EM; Hashad S; Lepore L; Mulaosmanovic V; Nielsen S; Prahalad S; Rigante D; Stanevicha V; Sterba G; Susic G; Takei S; Trauzeddel R; Zletni M; Ruperto N; Martini A; Cron RQ; Ravelli A;
Arthritis Rheumatol; 2014 Oct; 66(10):2871-80. PubMed ID: 25044674
[TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated Analysis.
Brossard P; Laveille C
Rheumatol Ther; 2024 Jun; 11(3):869-880. PubMed ID: 38662147
[TBL] [Abstract][Full Text] [Related]
18. Macrophage activation syndrome and cytokine-directed therapies.
Schulert GS; Grom AA
Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):277-92. PubMed ID: 24974063
[TBL] [Abstract][Full Text] [Related]
19. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
[TBL] [Abstract][Full Text] [Related]
20. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
Castillo L; Carcillo J
Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
